PCR Technologies Market Drivers and Opportunities [2020-2030]
The PCR technologies market size is projected to reach US$ 24,524.50 million by 2030 from US$ 13,101.87 million in 2022. The market is expected to register a CAGR of 8.2% during 2022–2030. The advancements in PCR technologies are likely to serve as one of the key trends in the market.
PCR Technologies Market Analysis
Factors driving the PCR technologies market growth are the rise in the incidence of target infectious diseases and genetic disorders, continual improvements in PCR technologies, and growing funding and investments. Furthermore, rising market penetration in emerging nations is likely to provide growth opportunities for market players in the PCR technologies market. PCR has evolved significantly over the years, resulting in the creation of faster, more sensitive, and highly efficient PCR methods. These breakthroughs include real-time PCR, digital PCR, and multiplex PCR, among others. Each iteration brings enhancement in speed, accuracy, and the capacity to detect many targets simultaneously, therefore broadening its applications in diagnostics and research, which is likely to boost the growth of the PCR technologies market.
PCR Technologies Market Overview
The use of PCR technology is being explored in several nonconventional applications, making molecular diagnosis more accessible and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The ultrafast PCR reduces the test duration by ten times compared to the previous tests by utilizing photothermal nanomaterials. In addition, the rise in the development of personalized medicine owing to the availability of particular genome testing and the developing field of nutrigenomics are fueling the growth of the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
PCR Technologies Market: Strategic Insights
PCR Technologies Market
-
CAGR (2022 - 2030)
8.2%
-
Market Size 2022
US$ 13,101.87 Million
-
Market Size 2030
US$ 24,524.50 Million
Market Dynamics
GROWTH DRIVERS
- Increasing Adoption of PCR Techniques
FUTURE TRENDS
- Rising Investments and Funds Availability for PCR Technologies
OPPORTUNITIES
- Advancements in PCR Technologies
Key Players
- Atila Biosystems
- Thermo Fisher Scientific Inc
- Takara Bio Inc
- Standard BioTools Inc
- F Hoffmann La Roche AG
- Bio Rad Laboratories Inc
- Agilent Technologies
- Biomerieux SA
- QIAGEN NV
- Promega Corporation
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Technology
- Real-Time PCR
- Conventional PCR
- Reverse Transcription PCR
- Digital PCR
- Multiplex RT PCR
- Hot Start PCR
- Others
Offerings
- Reagents and Consumables
- Instruments
- Software and Services
Application
- Gene Expression Analysis
- Genetic Sequencing
- Genotyping
- Nucleic Acid Synthesis
- Standard Validation
- Point of Care Diagnostics
- Environmental Application
- Others
End User
- Hospitals and Diagnostic Centers
- Academia and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
PCR Technologies Market: Strategic Insights
-
CAGR (2022 - 2030)8.2% -
Market Size 2022
US$ 13,101.87 Million -
Market Size 2030
US$ 24,524.50 Million
Market Dynamics
- Increasing Adoption of PCR Techniques
- Rising Investments and Funds Availability for PCR Technologies
- Advancements in PCR Technologies
Key Players
- Atila Biosystems
- Thermo Fisher Scientific Inc
- Takara Bio Inc
- Standard BioTools Inc
- F Hoffmann La Roche AG
- Bio Rad Laboratories Inc
- Agilent Technologies
- Biomerieux SA
- QIAGEN NV
- Promega Corporation
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Real-Time PCR
- Conventional PCR
- Reverse Transcription PCR
- Digital PCR
- Multiplex RT PCR
- Hot Start PCR
- Others
- Reagents and Consumables
- Instruments
- Software and Services
- Gene Expression Analysis
- Genetic Sequencing
- Genotyping
- Nucleic Acid Synthesis
- Standard Validation
- Point of Care Diagnostics
- Environmental Application
- Others
- Hospitals and Diagnostic Centers
- Academia and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
PCR Technologies Market Drivers and Opportunities
Rising Investments and Funds Availability for PCR Technologies to Favor Market Growth
Government and federal agencies around the world are progressively acknowledging the relevance of qPCR and dPCR products in genomics research. In the recent decade, the market has seen several funding programs to boost genomic research from both government and private institutions. Visby Medical (US), an infectious disease diagnostic business, obtained Phase 2 funding from the National Institutes of Health under its Rapid Acceleration of Diagnostics initiative in October 2020. EVONETIX LTD announced the completion of its Series B financing round in 2020. The company, led by new investor Foresite Capital, raised US$ 30 million (£23 million) in this round. These initiatives aim to conduct medical genomics-based investigations in customized medicine, such as PCR-based disease detection and treatment. Thus, with the increasing availability of financial support for maintaining R&D in disease-targeted genomics research activities, the need for PCR products is expected to increase, thereby driving market growth.
Increasing Adoption of PCR Techniques in Emerging Countries
In recent years, molecular methods such as PCR have progressed as diagnostic tools, enabling healthcare professionals to accurately diagnose various infectious diseases. PCR techniques are also being widely accepted and utilized in emerging countries. According to the World Health Organization (WHO) Report on the Establishment of PCR Laboratory in Developing Countries, WHO provides technical assistance to establish PCR laboratories in all 11 WHO Southeast Asia countries. Depending on their need, these facilities have adopted various PCR technologies such as reverse transcriptase PCR (RT-PCR), multiplex PCR, real-time PCR, in-situ PCR, and dPCR. The application of PCR technologies is increasing in clinical microbiology, biotechnology, virology, parasitology, and allied fields due to this tool's simple, rapid, and highly specific screening. Thus, the PCR technologies market in developing countries is expected to offer lucrative opportunities during the forecast period.
PCR Technologies Market Report Segmentation Analysis
Key segments that contributed to the derivation of the PCR technologies market analysis are technology, offerings, application, and end user.
- Based on technology, the PCR technologies market is classified into real-time PCR, conventional PCR, reverse transcription PCR, digital PCR, multiplex RT PCR, hot start PCR, and others. The real-time PCR segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR during the forecast period.
- In terms of offerings, the market is categorized into reagents and consumables, instruments, and software and services. The reagents and consumables segment held the largest share of the market in 2022 and is projected to register the highest CAGR during the forecast period.
- In terms of application, the PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostics, environmental application, and others. The gene expression analysis segment held the largest share of the market in 2022 and is anticipated to register the fastest CAGR during the forecast period.
- Based on end user, the market is segmented into hospitals and diagnostic centers, academia and research institutes, pharmaceutical and biotechnology companies, and others. The hospitals and diagnostic centers segment held the largest share of the market in 2022 and is projected to register the fastest CAGR during the forecast period.
PCR Technologies Market Share Analysis by Geography
The geographic scope of the PCR technologies market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the PCR technologies market. The market growth in this region is attributed to the rising demand for state-of-the-art products from bioanalytical instrument manufacturers and PCR companies, extensive R&D conducted across various academic and research institutes, and the presence of significant market players. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries. An upsurge in the acceptance and implementation of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. Further, Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
PCR Technologies Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 13,101.87 Million |
Market Size by 2030 | US$ 24,524.50 Million |
Global CAGR (2022 - 2030) | 8.2% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Technology
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
PCR Technologies Market News and Recent Developments
The PCR technologies market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the PCR technologies market are listed below:
- Agilent Technologies Inc. introduced a real-time reverse transcription (qRT) PCR-based diagnostic kit for SARS-CoV-2 RNA detection. The Agilent SARS-CoV-2 qRT-PCR Dx kit is an in vitro diagnostic reagent kit for detecting SARS-CoV-2 RNA using qRT-PCR. The single-tube assay enables greater efficiency, higher throughput, less consumption, and unambiguous results for testing outcomes confidence. (Source: Agilent Technologies Inc., Press Release, March 2021)
- Standard BioTools Inc. launched the X9 Real-Time PCR system, an innovative high-capacity genomics instrument offering superior efficiency. X9 provides high data output with over 9,000 individual nanoliter-volume reactions in a single run, providing cost-effective, comprehensive sample profiling with minimal operator involvement. (Source: Standard BioTools Inc., Press Release, October 2022)
PCR Technologies Market Report Coverage and Deliverables
The “PCR Technologies Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- PCR technologies market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- PCR technologies market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- PCR technologies market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the PCR technologies market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Offerings, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America region dominated the PCR technologies market in 2022.
The rising prevalence of genetic and infectious diseases and rising investments and funds availability for PCR technologies are the most influential factors responsible for market growth.
Atila Biosystems; Thermo Fisher Scientific, Inc.; Takara Bio Inc.; Standard BioTools Inc.; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc; Agilent Technologies; Biomerieux SA; QIAGEN NV; Promega Corporation; Becton, Dickinson, and Company; Visby Medical, Inc.; and Ellume Ltd are the market players in the PCR technologies market.
The estimated value of the PCR technologies market accounted for US$ 24,524.50 million in 2030.
The global PCR technologies market is estimated to register a CAGR of 8.2% during the forecast period 2022–2030.
The List of Companies - PCR Technology Market
- Thermo Fisher Scientific Inc
- Promega Corp
- QIAGEN NV
- bioMerieux SA
- Hoffmann-La Roche Ltd
- Bio-Rad Laboratories Inc
- Becton Dickinson and Co
- Atila Biosystems Inc
- Takara Bio Inc
- Standard BioTools Inc
- Agilent Technologies Inc
- Visby Medical Inc
- Ellume Ltd